PT-141

What is PT-141?

PT-141, known generically as Bremelanotide, is a synthetic peptide that represents a significantly modified derivative of alpha-melanocyte-stimulating hormone (α-MSH). It has been explored in clinical trials as a potential treatment for hypoactive sexual desire in both men and women. This peptide functions as an agonist for the melanocortin-4 (MC-4R) and melanocortin-1 (MC-1R) receptors, making it unique among similar compounds.

The primary focus of PT-141 is its ability to enhance sexual arousal. By binding predominantly to the MC-4R and MC-1R, PT-141 influences sexual function and response. This interaction with melanocortin receptors is crucial for its therapeutic effects, particularly in addressing issues related to sexual desire.

Emerging research indicates that PT-141’s agonistic activity may extend beyond sexual arousal, hinting at a role in stimulating the immune system as well. This multifaceted action positions PT-141 as a peptide with significant therapeutic potential for various physiological and clinical challenges.

Originating from melanotan 2 (MT-2), PT-141 is part of a lineage of synthetic melanocortins. Its diverse applications highlight its importance in addressing both sexual health and broader health concerns.

What Are the Benefits of PT-141?

• • Enhances Sexual Arousal:
    PT-141 has been extensively studied for its ability to enhance sexual arousal in both genders. Acting as an agonist for the melanocortin-4 receptor (MC-4R) and melanocortin-1 receptor (MC-1R), it influences the central nervous system pathways that regulate sexual response. Research indicates that PT-141 holds promise as a treatment for low sexual desire, demonstrating its capacity to activate melanocortin receptors linked to sexual function.
  • Boosts Immune Function:
    In addition to its role in sexual arousal, PT-141 has been shown to stimulate the immune system. The melanocortin receptors, particularly MC-1R, are known to play a role in modulating immune responses. Preliminary research suggests that PT-141’s engagement with these receptors may exert immunomodulatory effects, potentially influencing the body’s overall immune function. While the precise mechanisms and clinical ramifications of PT-141’s impact on immune health are still under investigation, its dual action on sexual arousal and immune response makes it a compelling subject for further study across various medical applications.

PRODUCTS ARE FOR RESEARCH PURPOSES ONLY